Vericel VCEL
NASDAQ VCEL
$40.19 -0.28 (-0.69%)
As of: Sep 4, 2026 · 3:59 PM EDT

Vericel (VCEL) Depreciation & Amortization (CF) (2010 - 2026)

Vericel (VCEL) posted Depreciation & Amortization (CF) of $3.6 million for Q2 2026, up 10.81% sequentially from $3.3 million in Q1 2026, and up 28.1% YoY from $2.8 million in Q2 2025.

Analysis

Vericel (VCEL) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

Vericel has reported Depreciation & Amortization (CF) for 17 years, with the latest figure at $3.6 million in Q2 2026.

  • Quarterly Depreciation & Amortization (CF) rose 28.1% year-over-year to $3.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $12.9 million (up 55.37% YoY) and the FY2025 annual result came in at $11.5 million, up 109.74% from the prior year.
  • Depreciation & Amortization (CF) climbed to $3.6 million in Q2 2026 per VCEL's latest filing, from $3.3 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $3.6 million in Q2 2026 and troughed at $873000.0 in Q1 2022.
  • A 5-year average of $1.8 million and a median of $1.3 million in 2024 frame the typical range for Depreciation & Amortization (CF).
  • The sharpest annual moves came in 2023 and 2025: Depreciation & Amortization (CF) increased 6.45% in 2023, then jumped 122.02% in 2025.
  • Over 5 years, Depreciation & Amortization (CF) stood at $1.0 million in 2022, then advanced by 10.59% to $1.1 million in 2023, then grew by 28.55% to $1.5 million in 2024, then surged by 109.07% to $3.1 million in 2025, then rose by 17.23% to $3.6 million in 2026.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $3.6 million, $3.3 million, and $3.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 56.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 123.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 40.52 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Vericel 2.05 Bn 1.89 Bn 56.40 Mn 3.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.62 Mn
Mar 31, 2026 3.27 Mn
Dec 31, 2025 3.09 Mn
Sep 30, 2025 2.94 Mn
Jun 30, 2025 2.83 Mn
Mar 31, 2025 2.69 Mn
Dec 31, 2024 1.48 Mn
Sep 30, 2024 1.33 Mn
Jun 30, 2024 1.32 Mn
Mar 31, 2024 1.38 Mn
Dec 31, 2023 1.15 Mn
Sep 30, 2023 1.15 Mn
Jun 30, 2023 1.17 Mn
Mar 31, 2023 1.16 Mn
Dec 31, 2022 1.04 Mn
Sep 30, 2022 1.00 Mn
Jun 30, 2022 1.10 Mn
Mar 31, 2022 873,000.00
Dec 31, 2021 765,000.00
Sep 30, 2021 700,000.00